Overactive Bladder and BPH clinical trial watch


This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes U.S. phase II, III, and IV overactive bladder trials that are currently recruiting participants as well as phase II BPH trials. This list is current as of Feb. 16, 2011.

Overactive Bladder

• Combined Behavioral and Drug Treatment of OAB in MenSponsor(s): University of Alabama at Birmingham
Identifier: NCT01175382

• Hypnotherapy for Treatment of OABSponsor(s): University of New Mexico
Identifier: NCT00793611

• Solifenacin Succinate (VESIcare) for the Treatment of OAB in Parkinson's DiseaseSponsor(s): University of South Florida, Astellas Pharma Inc.
Identifier: NCT01018264

• Local Anesthetic Treatments for OABSponsor(s): NorthShore University HealthSystem Research Institute, Berlex Foundation
Identifier: NCT00427648

• A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive BladderSponsor(s): Pfizer
Identifier: NCT00928070

Related Videos
Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
Daniel J. Heidenberg, MD, answers a question during a Zoom video interview
African American patient explaining issues to Asian doctor using tablet | Image Credit: © rocketclips - stockadobe.com
Todd M. Morgan, MD, answers a question during a Zoom video interview
3D illustration of prostate cancer cells | Image Credit: © Dr_Microbe - stock.adobe.com
Group of doctors reading a document | Image Credit: © Flamingo Images - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.